Drug Safety Information for RIFAMPIN (Rifampin)

Safety-related Labeling Changes for RIFADIN (RIFAMPIN) Rx Drug: FDA Link

Adverse Drug Reactions for RIFAMPIN* (Rifampin)

These charts and graphs are based on reports received through the FDA Adverse Event Reporting System (FAERS) program (see below).

Top 20 Adverse Effects Associated with RIFAMPIN
(reported in FDA Medwatch/FAERS Reports)

  Side Effect # of FDA Reports
1Pyrexia226
2Renal failure acute154
3Nausea*150
4Vomiting140
5Drug interaction127
6Rash97
7Thrombocytopenia95
8Anaemia95
9Dyspnoea93
10Diarrhoea*92
11Eosinophilia92
12Aspartate aminotransferase increased84
13Neutropenia84
14Alanine aminotransferase increased83
15Renal failure81
16Pruritus79
17Asthenia78
18Condition aggravated78
19Drug rash with eosinophilia and systemic symptoms77
20Drug ineffective*72

* This side effect also appears in "Top 10 Side Effects of RIFAMPIN " in the drug's Review Summary based on AskaPatient reviews.

Top 10 Reasons for Taking RIFAMPIN
(associated with FDA Medwatch/FAERS Reports)

Reason # of FDA Reports
1Tuberculosis1347
2Product used for unknown indication1105
3Pulmonary tuberculosis729
4Staphylococcal infection287
5Endocarditis200
6Infection157
7Antibiotic prophylaxis151
8Disseminated tuberculosis141
9Lymph node tuberculosis133
10Osteomyelitis133

*Also a top-10 reason in AskaPatient Review Summary.


Types of Adverse Events for RIFAMPIN

Total Reports Filed with FDA: 13250


Number of FDA Adverse Event Reports by Patient Age for RIFAMPIN

Total Reports Filed with FDA: 13250*


* Reports for drugs with the same active ingredients have been aggregated in this analysis: Rifampin (Rifadin iv, Rimactane, Rifampin, Rifadin)

Charts are based on 13250 reports filed with the FDA between 2004 and June 2015.

Adverse Event Reports are submitted to the FDA by pharmaceutical companies (mandatory reporting is required by manufacturers, distributors, or importers), health care providers such as doctors (voluntary reporting), and by patients themselves (voluntary reporting). More Information on FDA MedWatch (FDA Safety Information and Adverse Event Reporting Program)Voluntary reporting takes place under the FDA's MedWatch program, where health care professionals and consumers submit reports to FDA when they find a problem with a drug, medical device, biologic, or other FDA-regulated product. An adverse event is any undesirable experience or extreme side effect associated with the use of a medical product. Adverse events include: death, life threatening event, hospitalization, disability or permanent damage, congenital anomaly or birth defect, medical product use requiring a surgical or other intervention, or other serious medical situation believed to be caused by the drug.

Click to go back to search results and RIFAMPIN Reviews and Review Summary .

Analytics of FDA Adverse Event Reports Provided by Druginformer.com. FDA Drug Safety Information, including safety-related labeling updates, required post-approval safety studies, risk evaluation management strategies (REMS), alerts, and recalls are compiled by AskaPatient.com from the U.S. Food and Drug Administration.

Visit   DrugInformer.com more on RIFAMPIN's side effects.